Cargando…
Management of Mycoplasma genitalium infections – can we hit a moving target?
Mycoplasma genitalium is an etiological agent of sexually transmitted infections, but due to its fastidious growth requirements, only a few M. genitalium strains are available for determination of the activity of currently used and new antimicrobial agents. Recent clinical trials have demonstrated t...
Autores principales: | Jensen, Jørgen Skov, Bradshaw, Catriona |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545773/ https://www.ncbi.nlm.nih.gov/pubmed/26286546 http://dx.doi.org/10.1186/s12879-015-1041-6 |
Ejemplares similares
-
Azithromycin Failure in Mycoplasma genitalium Urethritis
por: Bradshaw, Catriona S., et al.
Publicado: (2006) -
Recent advances in understanding and combatting Mycoplasma genitalium
por: Peel, Joanne, et al.
Publicado: (2020) -
Increasing Macrolide and Fluoroquinolone Resistance in Mycoplasma genitalium
por: Murray, Gerald L., et al.
Publicado: (2017) -
Weighing Potential Benefits and Harms of Mycoplasma genitalium Testing and Treatment Approaches
por: Manhart, Lisa E., et al.
Publicado: (2022) -
Use of Pristinamycin for Macrolide-Resistant Mycoplasma genitalium Infection
por: Read, Tim R.H., et al.
Publicado: (2018)